| Product NDC: | 54092-253 |
| Proprietary Name: | Fosrenol |
| Non Proprietary Name: | lanthanum carbonate |
| Active Ingredient(s): | 750 mg/1 & nbsp; lanthanum carbonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54092-253 |
| Labeler Name: | Shire US Manufacturing Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021468 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20051123 |
| Package NDC: | 54092-253-90 |
| Package Description: | 6 BOTTLE in 1 PACKAGE (54092-253-90) > 15 TABLET, CHEWABLE in 1 BOTTLE (54092-253-15) |
| NDC Code | 54092-253-90 |
| Proprietary Name | Fosrenol |
| Package Description | 6 BOTTLE in 1 PACKAGE (54092-253-90) > 15 TABLET, CHEWABLE in 1 BOTTLE (54092-253-15) |
| Product NDC | 54092-253 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lanthanum carbonate |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20051123 |
| Marketing Category Name | NDA |
| Labeler Name | Shire US Manufacturing Inc. |
| Substance Name | LANTHANUM CARBONATE |
| Strength Number | 750 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |